FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

40395111000001102: Regdanvimab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jan 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1919521000001116 Regdanvimab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1919541000001114 Regdanvimab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regdanvimab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Regdanvimab 960mg/16ml solution for infusion vials Has specific active ingredient True Regdanvimab Inferred relationship Existential restriction modifier
Regkirona 960mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has specific active ingredient True Regdanvimab Inferred relationship Existential restriction modifier
Regkirona 960mg/16ml concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) 1 vial Has specific active ingredient True Regdanvimab Inferred relationship Existential restriction modifier
Regdanvimab 960mg/16ml solution for infusion vials 1 vial Has specific active ingredient True Regdanvimab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start